Drug Shortage Report for PAZEO
| Report ID | 103745 |
| Drug Identification Number | 02458551 |
| Brand name | PAZEO |
| Common or Proper name | PAZEO 0.7% SOLN 2.5ML |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | OLOPATADINE |
| Strength(s) | 0.7% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC |
| Packaging size | 2.5ML |
| ATC code | S01GX |
| ATC description | DECONGESTANTS AND ANTIALLERGICS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2020-01-27 |
| Actual start date | 2020-01-23 |
| Estimated end date | 2020-03-30 |
| Actual end date | 2020-03-30 |
| Shortage status | Resolved |
| Updated date | 2020-03-31 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v14 | 2020-03-31 | French | Compare |
| v13 | 2020-03-31 | English | Compare |
| v12 | 2020-03-20 | French | Compare |
| v11 | 2020-03-20 | English | Compare |
| v10 | 2020-03-09 | French | Compare |
| v9 | 2020-03-09 | English | Compare |
| v8 | 2020-02-28 | French | Compare |
| v7 | 2020-02-28 | English | Compare |
| v6 | 2020-01-28 | French | Compare |
| v5 | 2020-01-28 | English | Compare |
| v4 | 2020-01-28 | English | Compare |
| v3 | 2020-01-20 | French | Compare |
| v2 | 2020-01-20 | English | Compare |
| v1 | 2020-01-20 | English | Compare |
Showing 1 to 14 of 14